Tags

Type your tag names separated by a space and hit enter

FDA and the safe and appropriate antibiotic use of fluoroquinolones.
Lancet Infect Dis. 2016 Mar; 16(3):e11-2.LI

Authors+Show Affiliations

GST Micro LLC, Downingtown, PA 19335, USA. Electronic address: gtillotsonconsult@yahoo.com.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26973315

Citation

Tillotson, Glenn S.. "FDA and the Safe and Appropriate Antibiotic Use of Fluoroquinolones." The Lancet. Infectious Diseases, vol. 16, no. 3, 2016, pp. e11-2.
Tillotson GS. FDA and the safe and appropriate antibiotic use of fluoroquinolones. Lancet Infect Dis. 2016;16(3):e11-2.
Tillotson, G. S. (2016). FDA and the safe and appropriate antibiotic use of fluoroquinolones. The Lancet. Infectious Diseases, 16(3), e11-2. https://doi.org/10.1016/S1473-3099(16)00051-7
Tillotson GS. FDA and the Safe and Appropriate Antibiotic Use of Fluoroquinolones. Lancet Infect Dis. 2016;16(3):e11-2. PubMed PMID: 26973315.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - FDA and the safe and appropriate antibiotic use of fluoroquinolones. A1 - Tillotson,Glenn S, PY - 2015/12/16/received PY - 2016/01/14/accepted PY - 2016/3/15/entrez PY - 2016/3/15/pubmed PY - 2016/7/30/medline SP - e11 EP - 2 JF - The Lancet. Infectious diseases JO - Lancet Infect Dis VL - 16 IS - 3 SN - 1474-4457 UR - https://www.unboundmedicine.com/medline/citation/26973315/FDA_and_the_safe_and_appropriate_antibiotic_use_of_fluoroquinolones_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1473-3099(16)00051-7 DB - PRIME DP - Unbound Medicine ER -